wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36914445-237EF48C-1C8E-454F-BA59-289FC00F227A
Q36914445-237EF48C-1C8E-454F-BA59-289FC00F227A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36914445-237EF48C-1C8E-454F-BA59-289FC00F227A
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.
P2860
Q36914445-237EF48C-1C8E-454F-BA59-289FC00F227A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36914445-237EF48C-1C8E-454F-BA59-289FC00F227A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ba6398221f1d326cb1cf7a9d7790c52087f05fe
P2860
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia.